XML 99 R68.htm IDEA: XBRL DOCUMENT v3.20.1
SEGMENT INFORMATION (Summary of Reportable Segments) (Details)
$ in Thousands
3 Months Ended 27 Months Ended
Mar. 31, 2020
USD ($)
segment
Mar. 31, 2019
USD ($)
Mar. 31, 2020
USD ($)
Dec. 31, 2019
USD ($)
Financial information regarding the Company's reportable segments        
Number of reportable segments | segment 3      
Net sales $ 721,553 $ 744,460    
Acquisition related costs (2,274)      
Total Restructuring Initiatives 4,839 9,530    
Depreciation and amortization 50,806 47,489    
Interest expense (8,388) (9,214)    
Interest income 175 1,748    
Income before Income Taxes 78,036 89,999    
Capital Expenditures 61,625 51,742    
Total Assets 3,776,552   $ 3,776,552 $ 3,562,119
Employee severance        
Financial information regarding the Company's reportable segments        
Total Restructuring Initiatives 4,066      
Business Transformation        
Financial information regarding the Company's reportable segments        
Total Restructuring Initiatives 4,800 9,500    
Capital Expenditures     $ 40,000  
Beauty + Home        
Financial information regarding the Company's reportable segments        
Net sales 324,560 367,659    
Adjusted EBITDA 34,247 53,191    
Total Restructuring Initiatives 4,907 8,269    
Pharma        
Financial information regarding the Company's reportable segments        
Net sales 297,196 272,701    
Adjusted EBITDA 108,342 97,357    
Total Restructuring Initiatives (31) 326    
Food + Beverage        
Financial information regarding the Company's reportable segments        
Net sales 99,797 104,100    
Adjusted EBITDA 15,407 16,691    
Total Restructuring Initiatives 103 510    
Corporate & Other        
Financial information regarding the Company's reportable segments        
Adjusted EBITDA (13,828) (12,755)    
Total Restructuring Initiatives (140) 425    
Operating segment        
Financial information regarding the Company's reportable segments        
Net sales 730,357 752,724    
Operating segment | Beauty + Home        
Financial information regarding the Company's reportable segments        
Net sales 330,466 373,503    
Operating segment | Pharma        
Financial information regarding the Company's reportable segments        
Net sales 299,590 274,494    
Operating segment | Food + Beverage        
Financial information regarding the Company's reportable segments        
Net sales 100,301 104,727    
Intersegment        
Financial information regarding the Company's reportable segments        
Net sales 8,804 8,264    
Intersegment | Beauty + Home        
Financial information regarding the Company's reportable segments        
Net sales 5,906 5,844    
Intersegment | Pharma        
Financial information regarding the Company's reportable segments        
Net sales 2,394 1,793    
Intersegment | Food + Beverage        
Financial information regarding the Company's reportable segments        
Net sales $ 504 $ 627